Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms-Reference-Cited by-同舟云学术

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Published:2021-08-12 Issue: Volume: Page:
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Hoertel Nicolas^ORCID,Sánchez-Rico Marina^ORCID,Cougoule Céline,Gulbins Erich,Kornhuber Johannes^ORCID,Carpinteiro Alexander,Becker Katrin Anne,Reiersen Angela M.^ORCID,Lenze Eric J.,Seftel David,Lemogne Cédric^ORCID,Limosin Frédéric

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-021-01254-3.pdf

Reference16 articles.

1. Salles J, Briand-Mésange F, Trudel S, Ausseil J, Salles J-P, Chap H. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19? Mol Psychiatry. 2021:1–2. https://doi.org/10.1038/s41380-021-01221-y. Epub ahead of print.

2. Stip E, Arnone D, Abdel Aziz K, Javaid S. Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties. Mol Psychiatry. 2021:1–5. https://doi.org/10.1038/s41380-021-01222-x. Epub ahead of print.

3. Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01021-4 Epub ahead of print.

4. Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. SSRIs and SNRIs and Risk of Death or Intubation in COVID-19: Results from an Observational Study. medRxiv 2020.07.09.20143339; https://doi.org/10.1101/2020.07.09.20143339.

5. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9–20.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials;PLOS ONE;2024-05-16

2. Precision Medicine for COVID-19 Based on the Inflammatory Response;Infectious Diseases in Clinical Practice;2024-04-17

3. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial;eClinicalMedicine;2024-04

4. Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants;Viruses;2024-03-30

5. Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?;European Archives of Psychiatry and Clinical Neuroscience;2024-02-27